Oorsprong van het eerstegraads netwerk van David DeLucia
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 21 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met David DeLucia via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| ALLERGAN, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Washington University in St. Louis | College/University | Masters Business Admin | |
| XOMA CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
| COMPUGEN LTD. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| GLOBEIMMUNE, INC. | Pharmaceuticals: Other | Corporate Officer/Principal | |
| ANAPTYSBIO, INC. | Biotechnology | Director/Board Member | |
| Brown University | College/University | Undergraduate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree | |
| Stanford University | College/University | Undergraduate Degree Doctorate Degree | |
Incyte Pharmaceuticals, Inc.
 Incyte Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Incyte Pharmaceuticals, Inc. engages in the provision of biopharmaceutical services. The company was founded in April, 1991 is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| McGill University | College/University | Masters Business Admin | |
ActivX Biosciences, Inc.
 ActivX Biosciences, Inc. Pharmaceuticals: MajorHealth Technology ActivX Biosciences, Inc. develops pharmaceutical products. It discovers and develops small molecule drugs for major unmet medical needs. The company was founded in 2000 and is located in La Jolla, CA | Pharmaceuticals: Major | Founder Chief Executive Officer | |
| Fairfield University | College/University | Undergraduate Degree | |
| Hartwick College | College/University | Undergraduate Degree | |
| Jacksonville State University | College/University | Undergraduate Degree | |
| St. Louis University | College/University | Doctorate Degree | |
| University of Michigan | College/University | Undergraduate Degree | |
| The University of North Carolina at Chapel Hill | College/University | Undergraduate Degree | |
| The University of California, San Francisco | College/University | Doctorate Degree | |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Biotechnology | Corporate Officer/Principal | |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
| Instituto Tecnológico y de Estudios Superiores de Monterrey | College/University | Undergraduate Degree | |
The State Bar of California
 The State Bar of California Miscellaneous Commercial ServicesCommercial Services The State Bar of California operates as an official attorney licensing agency. The non-profit company is based in San Francisco, CA. Elizabeth Rindskopf Parker has been the CEO of the company since 2015. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Skjerven, Morrill, MacPherson, Franklin & Friel LLP
 Skjerven, Morrill, MacPherson, Franklin & Friel LLP Miscellaneous Commercial ServicesCommercial Services Skjerven, Morrill, MacPherson, Franklin & Friel LLP operates as a intellectual property boutique. The company is headquartered in San Jose, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Johnson & Johnson, Inc.
 Johnson & Johnson, Inc. Insurance Brokers/ServicesFinance Johnson & Johnson, Inc. provides insurance brokerage services. The company was founded in 1930 and is headquartered in Mount Pleasant, SC. | Insurance Brokers/Services | Director of Finance/CFO | |
Pharma International, Inc.
 Pharma International, Inc. Miscellaneous Commercial ServicesCommercial Services Pharma International, Inc. provides web and package design services to life science, health and other companies to solve their business problems. It specializes in strategic planning, clinical education, patient education, web and interactive. The company is headquartered in Syracuse, NY. | Miscellaneous Commercial Services | Human Resources Officer | |
| Nanjing Medical University | College/University | Undergraduate Degree | |
| Lilly Diabetes | Corporate Officer/Principal | ||
| Janssen Alzheimer Immunotherapy | Corporate Officer/Principal | ||
Arch Oncology, Inc.
 Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Berkeley Law University of California | College/University | Graduate Degree | |
EMEA Capital LLP
 EMEA Capital LLP Investment ManagersFinance EMEA Capital LLP is a privately-held investment management firm which was founded by Osman Semerci in 2008. Headquartered in London, the firm provides asset management services to individual and institutional clients. | Investment Managers | Corporate Officer/Principal | |
| Compugen, Inc. (United States) | Corporate Officer/Principal | ||
| Kellogg School of Management | College/University | Masters Business Admin | |
| Daniels College of Business | College/University | Masters Business Admin | |
| Revelle College | College/University | Undergraduate Degree | |
FibroGen (China) Medical Technology Development Co. Ltd.
 FibroGen (China) Medical Technology Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of FibroGen, Inc., FibroGen (China) Medical Technology Development Co., Ltd. is a biomedical technology company based in Beijing, China. FibroGen () is dedicated to developing new mechanisms of action or "best-in-class" innovative drugs and medical devices to meet the unmet clinical needs of Chinese patients. The Chinese company also provides a platform to report adverse events related to FibroGen roxadustat products. The private company was founded in 2011. Christine Chung L. has been the CEO of the company since 2019. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Calidi Biotherapeutics, Inc. (United States)
 Calidi Biotherapeutics, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Calidi Biotherapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development of a cell delivery system for oncology treatments. The company was founded by Allan Camaisa and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| FibroGen International (Hong Kong) Ltd. | Director/Board Member | ||
| Keyhole Therapeutics, Inc. | Chief Executive Officer | ||
| CALIDI BIOTHERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Janssen Global Services LLC
 Janssen Global Services LLC Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Janssen Global Services LLC develops treatments for patients in therapeutic areas of healthcare. The private company is based in Raritan, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistieken
Internationaal
| Verenigde Staten | 42 |
| China | 3 |
| Israël | 2 |
| Japan | 2 |
| Canada | 2 |
Sectoraal
| Health Technology | 20 |
| Consumer Services | 19 |
| Commercial Services | 7 |
| Finance | 3 |
Operationeel
| Director/Board Member | 55 |
| Corporate Officer/Principal | 48 |
| Independent Dir/Board Member | 20 |
| Undergraduate Degree | 17 |
| Chief Executive Officer | 10 |
Sterkste connecties
| Insiders | |
|---|---|
| Benjamin Cravatt | 19 |
| Jeffrey Henderson | 18 |
| May Kin Ho | 16 |
| Jeffrey Edwards | 13 |
| James Schoeneck | 12 |
| Aoife Brennan | 10 |
| Gerald Lema | 9 |
| Kirk A. Christoffersen | 9 |
| Suzanne Blaug | 8 |
| Elias Kouchakji | 7 |
| Christine Chung L. | 7 |
| John Hunter | 7 |
| Leanne C. Price | 6 |
| Michael D. Lowenstein | 5 |
| Thane Wettig | 4 |
- Beurs
- Insiders
- David DeLucia
- Bedrijfsconnecties
